-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0082maternity.pdf
February 23, 2012 - The severity of depression and comorbid psychological problems (for
example, anxiety, panic attacks
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0084maternity.pdf
February 23, 2012 - The severity of depression and comorbid psychological problems (for
example, anxiety, panic attacks
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0085maternity.pdf
February 23, 2012 - The severity of depression and comorbid psychological problems (for
example, anxiety, panic attacks
-
www.talkingquality.ahrq.gov/sites/default/files/publications/files/casalino_idkeydsr.pdf
February 01, 2014 - and co-location systems of primary care and mental health care on outcomes
including depression, anxiety
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/system/delivery-system-initiative/casalino/paper/casalino_idkeydsr.pdf
February 01, 2014 - and co-location systems of primary care and mental health care on outcomes
including depression, anxiety
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/tobaccogenrefs.pdf
January 01, 2010 - placebo-controlled evaluation of the effects of
buspirone on smoking cessation: differences
between high- and low-anxiety